Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gustavo Pacheco-Rodriguez

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
The American Journal of Pathology|July 23, 2013
Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor geneWendy K Steagall, Gustavo Pacheco-Rodriguez, Connie G Glasgow, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2009
Interaction of phosphodiesterase 3A with brefeldin A-inhibited guanine nucleotide-exchange proteins BIG1 and BIG2 and effect on ARF1 activityErmanno Puxeddu, Marina Uhart, Chun-Chun Li, et al.
American Journal of Respiratory and Critical Care Medicine|January 31, 2015
Tuberous sclerosis complex 2 loss of heterozygosity in patients with lung disease and cancerLi Zhang, Gustavo Pacheco-Rodriguez, Wendy K Steagall, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2009
Chemokine-enhanced chemotaxis of lymphangioleiomyomatosis cells with mutations in the tumor suppressor TSC2 geneGustavo Pacheco-Rodriguez, Fumiyuki Kumaki, Wendy K Steagall, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 8, 2004
Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosisDenise M Crooks, Gustavo Pacheco-Rodriguez, Rosamma M DeCastro, et al.
American Journal of Respiratory and Critical Care Medicine|April 24, 2010
Effects of prolactin on TSC2-null Eker rat cells and in pulmonary lymphangioleiomyomatosisYasuhiro Terasaki, Kinnosuke Yahiro, Gustavo Pacheco-Rodriguez, et al.
Lymphatic Research and Biology|February 11, 2010
Involvement of lymphatics in lymphangioleiomyomatosisConnie G Glasgow, Angelo Taveira-DaSilva, Gustavo Pacheco-Rodriguez, et al.
BMC Pulmonary Medicine|September 24, 2022
Computer grading of lung disease severity in patients with lymphangioleiomyomatosis referred for transplantationAngelo M Taveira-DaSilva, Vissaagan Gopalakrishnan, Jianhua Yao, et al.
The Journal of Investigative Dermatology|March 28, 2021
Long-Term Effects of Sirolimus on Human Skin TSC2-Null Fibroblast‒Like CellsXiong Cai, Qingyuan Fan, Gi Soo Kang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2008
Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomasShaowei Li, Fumiko Takeuchi, Ji-An Wang, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
The American Journal of Pathology|July 23, 2013
Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor geneWendy K Steagall, Gustavo Pacheco-Rodriguez, Connie G Glasgow, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2009
Interaction of phosphodiesterase 3A with brefeldin A-inhibited guanine nucleotide-exchange proteins BIG1 and BIG2 and effect on ARF1 activityErmanno Puxeddu, Marina Uhart, Chun-Chun Li, et al.
American Journal of Respiratory and Critical Care Medicine|January 31, 2015
Tuberous sclerosis complex 2 loss of heterozygosity in patients with lung disease and cancerLi Zhang, Gustavo Pacheco-Rodriguez, Wendy K Steagall, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2009
Chemokine-enhanced chemotaxis of lymphangioleiomyomatosis cells with mutations in the tumor suppressor TSC2 geneGustavo Pacheco-Rodriguez, Fumiyuki Kumaki, Wendy K Steagall, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 8, 2004
Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosisDenise M Crooks, Gustavo Pacheco-Rodriguez, Rosamma M DeCastro, et al.
American Journal of Respiratory and Critical Care Medicine|April 24, 2010
Effects of prolactin on TSC2-null Eker rat cells and in pulmonary lymphangioleiomyomatosisYasuhiro Terasaki, Kinnosuke Yahiro, Gustavo Pacheco-Rodriguez, et al.
Lymphatic Research and Biology|February 11, 2010
Involvement of lymphatics in lymphangioleiomyomatosisConnie G Glasgow, Angelo Taveira-DaSilva, Gustavo Pacheco-Rodriguez, et al.
BMC Pulmonary Medicine|September 24, 2022
Computer grading of lung disease severity in patients with lymphangioleiomyomatosis referred for transplantationAngelo M Taveira-DaSilva, Vissaagan Gopalakrishnan, Jianhua Yao, et al.
The Journal of Investigative Dermatology|March 28, 2021
Long-Term Effects of Sirolimus on Human Skin TSC2-Null Fibroblast‒Like CellsXiong Cai, Qingyuan Fan, Gi Soo Kang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2008
Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomasShaowei Li, Fumiko Takeuchi, Ji-An Wang, et al.
Pageof 6